Editorial: Development of Humanized Mouse Models for Infectious Diseases and Cancer. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

Editorial: Development of Humanized Mouse Models for Infectious Diseases and Cancer.

Moriya Tsuji, Ramesh Akkina

Author Information

Moriya Tsuji: Aaron Diamond AIDS Research Center, Affiliate of the Rockefeller University, New York, NY, United States.
Ramesh Akkina: Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, United States.

PMID: 31998319 DOI: 10.3389/fimmu.2019.03051

No abstract text available.

humanized mice for HIV humanized mice in cancer research humanized mice in infectious disease research improved humanized mouse models malaria new humanized mouse models vaccines and therapeutics

R01 AI120021/NIAID NIH HHS
R01 AI123234/NIAID NIH HHS

Animals

Communicable Diseases

Disease Models, Animal

Humans

Mice

Neoplasms

Editorial Research Support, N.I.H., Extramural

Generation of improved humanized mouse models for human infectious diseases.Humanized mouse models for anti-cancer therapy.Humanized mouse models to study human diseases.Humanized mouse models: Application to human diseases.Editorial: Humanized Mouse Models to Study Immune Responses to Human Infectious Organisms.Mouse models for human infectious diseases.Editorial. Mouse models of infectious disease.Humanized mouse models for organ-specific autoimmune diseases.Humanized mouse models of immunological diseases and precision medicine.Animal models for viral diseases: Non-human primate and humanized mouse models for viral infections.

Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety.Evaluating the Clinical and Immune Responses to Spotted Fever Rickettsioses in the Guinea Pig-Tick-Rickettsia System.Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell Phenotypes.Advances in Transgenic Mouse Models to Study Infections by Human Pathogenic Viruses.Advances in Therapeutic Cancer Vaccines, Their Obstacles, and Prospects Toward Tumor Immunotherapy.